Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harriet Corvol

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Thorax|December 4, 2024
Surfactant protein B deficiency: the RespiRare cohortManon Fleury, Céline Delestrain, Léa Roditis, et al.
Journal of Clinical Medicine|November 13, 2020
First Wave of COVID-19 in French Patients with Cystic FibrosisHarriet Corvol, Sandra de Miranda, Lydie Lemonnier, et al.
The Journal of Clinical Endocrinology and Metabolism|November 8, 2019
Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related TraitsMelis A Aksit, Rhonda G Pace, Briana Vecchio-Pagán, et al.
Frontiers in Public Health|December 1, 2022
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)Nadia Oubaya, Thibaud Pombet, Celine Delestrain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2018
AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestationsRebecca J Darrah, Frank J Jacono, Neha Joshi, et al.
NPJ Genomic Medicine|March 28, 2018
Improving imputation in disease-relevant regions: lessons from cystic fibrosisNaim Panjwani, Bowei Xiao, Lizhen Xu, et al.
BMC Infectious Diseases|February 3, 2016
Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemyJulie Bucher, Pierre-Yves Boelle, Dominique Hubert, et al.
The Journal of Pediatrics|March 16, 2015
Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic FibrosisMelissa R Miller, David Soave, Weili Li, et al.
American Journal of Respiratory and Critical Care Medicine|October 12, 2019
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic FibrosisPierre-Régis Burgel, Anne Munck, Isabelle Durieu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2020
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisRebecca Cosgriff, Susannah Ahern, Scott C Bell, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Thorax|December 4, 2024
Surfactant protein B deficiency: the RespiRare cohortManon Fleury, Céline Delestrain, Léa Roditis, et al.
Journal of Clinical Medicine|November 13, 2020
First Wave of COVID-19 in French Patients with Cystic FibrosisHarriet Corvol, Sandra de Miranda, Lydie Lemonnier, et al.
The Journal of Clinical Endocrinology and Metabolism|November 8, 2019
Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related TraitsMelis A Aksit, Rhonda G Pace, Briana Vecchio-Pagán, et al.
Frontiers in Public Health|December 1, 2022
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)Nadia Oubaya, Thibaud Pombet, Celine Delestrain, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 26, 2018
AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestationsRebecca J Darrah, Frank J Jacono, Neha Joshi, et al.
NPJ Genomic Medicine|March 28, 2018
Improving imputation in disease-relevant regions: lessons from cystic fibrosisNaim Panjwani, Bowei Xiao, Lizhen Xu, et al.
BMC Infectious Diseases|February 3, 2016
Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemyJulie Bucher, Pierre-Yves Boelle, Dominique Hubert, et al.
The Journal of Pediatrics|March 16, 2015
Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic FibrosisMelissa R Miller, David Soave, Weili Li, et al.
American Journal of Respiratory and Critical Care Medicine|October 12, 2019
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic FibrosisPierre-Régis Burgel, Anne Munck, Isabelle Durieu, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2020
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisRebecca Cosgriff, Susannah Ahern, Scott C Bell, et al.
Pageof 15